Late treatment study
et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa791 (Peer Reviewed)
Compassionate use of hydroxych loroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital
Retrospective of 89 hospitalized patients, survival HR 0.89 [0.23-3.47], not statistically significant. Authors note that unmeasured confounders may have persisted and the study may be underpowered.
death, ↓11.0%, p=0.88
Please send us corrections, updates, or comments.